Finance

Lists
08HH:FRA
Shanghai Fosun Pharmaceutical (Group) Ord Shs H
€1,84
+0,05%
(+0,0010) 1D
23 Okt., 21:00:00 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 08HH...
Open
€1,84
High
€1,84
Low
€1,84
Mkt. cap
65,97 mjd
Avg. vol.
365,00
Volume
0,00
52-wk high
€2,60
52-wk low
€1,66
No. of employees
41 k
Open
€1,84
High
€1,84
Low
€1,84
Mkt. cap
65,97 mjd
Avg. vol.
365,00
Volume
0,00
52-wk high
€2,60
52-wk low
€1,66
No. of employees
41 k
News stories
From web sources and news partners
Profile
Shanghai Fosun Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company. It is mostly owned by Fosun International. As of 2018, the A shares of the company is a constituent of SSE 180 Index as well as its sub-index SSE MidCap Index. The company was ranked 1,840th in 2020 edition of the Forbes Global 2000, a list of top listed companies of the world. Wikipedia
About Shanghai Fosun Pharmaceutical (Group) Ord Shs H
CEOLiu Yi | Wen Deyong
Employees40,7 k
Founded1994
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
9,88 mjd
12,27 mjd
10,07 mjd
10,37 mjd
Cost of goods sold
5,08 mjd
5,65 mjd
5,07 mjd
5,23 mjd
Cost of revenue
5,08 mjd
5,65 mjd
5,07 mjd
5,23 mjd
Research and development expenses
1,01 mjd
1,28 mjd
896,79 m
1,19 mjd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,10 mjd
4,44 mjd
3,27 mjd
3,35 mjd
Operating expense
4,04 mjd
5,92 mjd
4,19 mjd
4,63 mjd
Total operating expenses
9,12 mjd
11,57 mjd
9,26 mjd
9,86 mjd
Operating income
758,38 m
699,05 m
813,78 m
505,27 m
Other non operating income
-116,85 m
107,33 m
2,03 m
-13,28 m
EBT including unusual items
1,12 mjd
1,27 mjd
1,36 mjd
1,23 mjd
EBT excluding unusual items
1,49 mjd
1,10 mjd
1,21 mjd
1,07 mjd
Income tax expense
162,98 m
82,80 m
277,92 m
159,73 m
Effective tax rate
14,57%
6,50%
20,47%
13,00%
Other operating expenses
-92,19 m
117,57 m
19,04 m
74,01 m
Net income
821,33 m
847,27 m
870,83 m
850,64 m
Net profit margin
8,31%
6,91%
8,64%
8,20%
Earnings per share
-
-
-
-
Interest and investment income
1,05 mjd
732,13 m
689,67 m
938,86 m
Interest expense
-321,25 m
-291,32 m
-296,51 m
-310,88 m
Net interest expenses
727,28 m
440,80 m
393,16 m
627,98 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,39 mjd
1,47 mjd
1,59 mjd
1,24 mjd
Gain or loss from assets sale
2,12 m
-69,35 m
-
-195,23 k
Upcoming events
AI content may include mistakes. Learn more
Google-programme